ARTICLE | Management Tracks
Patricia Drake to lead commercial at Innoviva’s specialty unit
Plus: Thomas Mehrling name CEO of Swiss biotech Release, and Tenaya CSO Hoey stepping down
July 2, 2024 12:12 AM UTC
Innoviva Inc. (NASDAQ:INVA) hired Patricia Drake as chief commercial officer of subsidiary Innoviva Specialty Therapeutics Inc., which markets infectious disease and critical care products. Drake, a longtime veteran of Merck & Co. Inc. (NYSE:MRK), was most recently SVP, CCO at Trevena Inc. (NASDAQ:TRVN).
Switzerland-based Release Therapeutics S.A. named Thomas Mehrling as CEO. Mehrling was CEO of Laevoroc Oncology AG, a company he founded. Release is developing a technology capable of delivering therapeutic proteins through the blood-brain barrier to treat CNS disorders. ...